Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients

Diabetic Medicine

Volumn 25, Issue 1, 2008, Pages 45-50

  Targher, G ^a,b,c   Bertolini, L ^a   Zenari, L ^a   Lippi, G ^b   Pichiri, I ^b   Zoppini, G ^b   Muggeo, M ^b   Arcaro, G ^a  

^a SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Epidemiology; Macrovascular disease; Retinopathy; Type 2 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PROTEINURIA; WAIST CIRCUMFERENCE;

DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; STROKE;

EID: 38049139343     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02327.x     Document Type: Article

References (21)

1. Van Hecke MV, Dekker JM, Stehouwer CDA, Polak BCP, Fuller JH, Sjolie AK et al. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence. The EURODIAB Prospective Complications Study. Diabetes Care 2005 28 : 1383 1389.
2. Torffvit O, Lovestam-Adrian M, Agardh E, Agardh CD. Nephropathy, but not retinopathy, is associated with the development of heart disease in Type 1 diabetes: a 12-year observation study of 462 patients. Diabet Med 2005 22 : 723 729.
3. Klein BE, Klein R, McBride PE, Cruickshanks KS, Palta M, Knudtson MD et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiology study of diabetic retinopathy. Arch Intern Med 2004 164 : 1917 1924.
4. Cusick M, Meleth AD, Agron E, Fisher MR, Reed GF, Knatterud GL et al. Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27. Diabetes Care 2005 28 : 617 625.
5. Hanis CL, Chu HH, Lawson K, Hewett-Emmett D, Barton SA, Schull WJ et al. Mortality of Mexican Americans with NIDDM. Retinopathy and other predictors in Starr County, Texas. Diabetes Care 1993 16 : 82 89.
6. Miettinen H, Haffner SM, Letho S, Ronnemaa T, Pyorala K, Laakso M. Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care 1996 19 : 1445 1448.
7. Van Hecke MV, Dekker JM, Nijpels G, Moll AC, Van Leiden HA, Heine RJ et al. Retinopathy is associated with cardiovascular and all-cause mortality in both diabetic and non-diabetic subjects. The Hoorn study. Diabetes Care 2003 26 : 2958.
8. Fuller JH, Stevens LK, Wang SL. Risk factors for cardiovascular mortality and morbidity: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001 44 : S54 S64.
9. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 1999 117 : 1487 1495.
10. Juutilainen A, Letho S, Ronnemaa T, Pyorala K, Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 2007 30 : 292 299.
11. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R et al. Non-alcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005 54 : 3541 3546.
12. Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M et al. Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003 110 : 1677 1682.
13. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003 139 : 137 147.
14. Harvey JN, Hood K, Platts J, Devarajoo S, Meadows PA. Prediction of albumin excretion rate from albumin-to-creatinine ratio. Diabetes Care 1999 22 : 1597 1598.
15. Targher G, Bertolini L, Tessari R, Zenari L, Arcaro G. Retinopathy predicts future cardiovascular events among type 2 diabetic patients. The Valpolicella Heart Diabetes Study. Diabetes Care 2006 29 : 1178.
16. Nguyen TT, Wong TY. Retinal vascular manifestations of metabolic disorders. Trends Endocrinol Metab 2006 17 : 262 268.
17. Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy. Diabet Med 2005 22 : 999 1004.
18. Van Hecke MV, Dekker JM, Nijpels G, Moll AC, Heine RJ, Bouter LM et al. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia 2005 48 : 1300 1306.
19. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE et al. UKPDS 50 - Risk factors for incidence and progression of retinopathy in type 2 diabetes over 6 years from diagnosis. Diabetologia 2001 44 : 156 163.
20. Poulaki V, Miller JW. Diabetic retinopathy. In : Mantzoros CS ed. Obesity and Diabetes. Totowa, NJ : Humana Press, 1997 17 : 291 318.
21. Gray RP, Yudkin JS. Cardiovascular disease in diabetes mellitus. In : Pickup J, Williams G eds. Textbook of Diabetes, 2nd edn. Oxford : Blackwell Science, 1997 57 : 1 22.